Vasoplegia in Cardiac Surgery: Pave the Way for Prevention

IN THIS ISSUE of the Journal of Cardiothoracic and Vascular Anesthesia, van Vessem et al.1 conducted a retrospective cohort study investigating the risk factors of vasoplegia in patients undergoing mitral valve repair for functional mitral regurgitation. In their study, vasoplegia was defined as administration of norepinephrine ≥0.2 μg/kg/min and/or any dose of terlipressin combined with a cardiac index ≥2.2 L/min/m2 for at least 12 consecutive hours, starting within the first 3 days after surgery.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Tags: Editorial Source Type: research